Bustamante et al. (18) analyzed NT-proBNP levels alongside other biomarkers within the STROKE-CHIP study in 1,308 patients with suspected stroke presenting within 6 hours of symptom onset. The gene discussed is NPPB; the disease is stroke disorder.